| 產品編號 | bs-43077P |
| 英文名稱 | Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike trimer protein, C-His (HEK293) |
| 中文名稱 | 重組SARS冠狀病毒2奧密克戎變異株S-ECD三聚體蛋白 |
| 別 名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike trimer protein, C-His (HEK293) |
| 理論分子量 | 137 kDa |
| 檢測分子量 | 150-180 |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | ＞0.5 mg/ml |
| 物 種 | SARS-Cov-2 |
| 序 列 | 16-1213/1273 |
| 純 度 | >90% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內毒素 | Not analyzed |
| 表達系統 | HEK293 cell |
| 活性 | Not tested |
| 標簽 | C-His |
| 緩 沖 液 | PBS (pH7.4). |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產品介紹 |
The SARS-CoV-2 Spike protein (with mutations A67V, HV69-70del, T95I, G142D, VYY143-145del,N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K,G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, F817P, N856K, A892P, A899P, A942P, Q954H, N969K, L981F, K986P, V987P and R683A, R685A).The mutations were identified in the SARS-CoV-2 variant (known as Omicron/B.1.1.529) which emerged in the South Africa. |
| 產品圖片 |
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a indirect ELISA. Immobilized SARS-CoV-2 Spike trimer Protein (His Tag) (Omicron/B.1.1.529) (Cat: bs-43077P) at 2μg/mL (100 μL/Well) can bind Anti-SARS-CoV-2 Spike Monoclonal antibody (Cat:bsm-41622M&bsm-41476M&bsm-41630M).
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2μg/mL (100 μL/Well) can bind SARS-CoV-2 Spike trimer Protein (His Tag) (Omicron/B.1.1.529) (Cat: bs-43077P), the EC50 is 1.5μg/mL.
|
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關于肽鏈的設計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
